Cardlytics shareholders approve reverse stock split authorization range of 1-for-5 to 1-for-15

• Cardlytics held its annual meeting on May 20, 2026.
• Shareholders backed a board-authorized reverse stock split, allowing a 1-for-5 to 1-for-15 ratio, with a matching cut in authorized common shares; the board can choose whether to implement the change before the 2027 annual meeting.
• Deloitte & Touche was ratified as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cardlytics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-036875), on May 20, 2026, and is solely responsible for the information contained therein.